At #ASHG2026, Cristina Gamba & Philipp Rescheneder show how long nanopore reads and dedicated tools resolve repeat expansions and allele-specific variation in genomic regions that standard approaches often can't reach.
@nanoporetech.com
Oxford Nanopore
@nanoporetech.com
We empower people to explore and answer biological questions with our transformative sensing technology.
@nanoporetech.com@nanoporetech.comAbstract submission for London Calling 2027 is now open! Submit an abstract for a chance to present your breakthroughs and real-world impact at the largest nanopore sequencing conference of the year.
Check out last year's video to see what it's all about.
@nanoporetech.comAntibody development, end-to-end with one solution. Antibody discovery involves screening, confirming and characterising at multiple stages, and nanopore sequencing can support all of them.
See how Pfizer has been applying this across their own workflow: https://bit.ly/4AlvF4t
@nanoporetech.comSee the targets you need and the biology you didn't expect. At #ASHG2026, Ellie Juarez & Miguel Reis show how Adaptive Sampling is reimagining targeted sequencing by letting you define, target, and enrich while you sequence - with no fixed panel required.
https://bit.ly/4dR8LYW
@nanoporetech.comWhat if you could see RNA exactly as it exists in the cell? Discover how direct RNA Oxford Nanopore sequencing captures transcripts without conversion or amplification, revealing biology that might otherwise be missed.
Find out more: https://bit.ly/4x7PBF3
@nanoporetech.comJoin researchers from Jessa Hospital and Tampa General Hospital who will share their clinical research workflow considerations, validation data, and implementation insights using nanopore sequencing and BugSeq analysis for fungal pathogen ID.
RUO
@nanoporetech.comAt our Industry Education Session at #ASHG26 we'll share the latest updates on nanopore sequencing before Debarshi Mustafi shows how technology resolves difficult variants in inherited retinal disease and retinoblastoma.
Learn more: https://bit.ly/4dnfGcl
@nanoporetech.comWastewater plants are vast tanks of bacteria doing humanity’s dirtiest job, yet most have never been named. Researchers just catalogued 54K genomes across 83 plants worldwide using nanopore technology. 82% were unknown to science. https://bit.ly/3SQt01J
@nanoporetech.comThis #WorldAnimalDay, we’re highlighting researchers around the world who are using genomics to better understand, monitor and protect vulnerable species. Learn more about the ORG.one project here: https://bit.ly/4xplkCs
@nanoporetech.comAt #nanporeconf, Dr. Chanatjit Cheawsamoot made the case that long-read sequencing is ready to leave the academic bubble. In Thailand, her team is already using it alongside current tests to identify variants in rare disease patients that might otherwise be missed.
For RUO.
@nanoporetech.com85% of childhood cancers are curable, yet global survival rates are 20%. Nickhill Bhakta shares how the DIVIA consortium is exploring the potential of adaptive sampling to democratise access to better cancer characterisation and treatment globally.
https://bit.ly/4jhbChk
@nanoporetech.comThis is ORG one.
Find out more: https://nanoporetech.com/oo?utm_campaign=AnythingAnyoneAnywhere&utm_content=1791019500&utm_medium=social&utm_source=bluesky
@nanoporetech.comSee more biology with gold-standard methylation calls.
In our benchmarking, the Oxford Nanopore confidently called ~10% more CpGs than Illumina bisulfite sequencing.
@nanoporetech.comDelayed answers & missed pathogens can be fatal for those with uterine infections.
Researchers are exploring the potential of nanopore sequencing to rapidly characterise pathogens that other methods miss.
@nanoporetech.comToday we published a new report building on discussions with over 50 leaders from #healthcare, #research and industry at our recent Health Summit in Singapore.
Learn more: https://bit.ly/4rELFdD
@nanoporetech.comWe're proud to join @GeneticAlliance's global rare disease programme, RISE, helping expand access to genomic testing for families with unresolved genetic conditions and supporting evidence generation for nanopore sequencing.
Learn more: https://bit.ly/4hsY6WR
@nanoporetech.comAt #ASHG2026, Cora Vacher opens our Industry Education Session on Adaptive Sampling and multiomic insight, before Debarshi Mustafi shows how long reads resolve difficult variants in inherited retinal disease and retinoblastoma.
@nanoporetech.comEveryone should have access to healthcare, even in remote regions. In the #nanoporeconf studio, Robert A. Edwards shared how portable nanopore sequencing has the potential to address gaps, making genomics more accessible to everyone.
@nanoporetech.comRapid answers could make a real difference for people facing a brain tumour diagnosis. A new NHS pilot is expanding rapid genomic classification across England, with the ambition to build a joined-up approach & bring potential benefits to more patients.
@nanoporetech.comOn-the-spot pathogen identification. From initial characterisation of genomes to the rapid identification of variants, portable and accessible nanopore technology enables quick responses to public health emergencies globally. See what you're missing. https://bit.ly/4ArKtyk #WYMM